Kurz gefasst
Kommentar in der Zeitschrift Cancer Cell, 2024. Verfasst von John Anderson. Beteiligte Einrichtung: UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK. Electronic address: j.anderson@ucl.ac.uk. Hauptthemen laut MEDLINE: Neuroblastoma, Calcium-Binding Proteins. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
An ideal cell surface target has ubiquitously high cancer expression, absence from healthy tissues, and an essential role cancer initiation and/or maintenance. In this issue of Cancer Cell, Hamilton et al. combine proteomics, transcriptomics, epigenomics, and dependency databases to identify DLK1, a novel immunotherapeutic target for neuroblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK. Electronic address: j.anderson@ucl.ac.uk.
Zitieren
APA
Anderson, J. (2024). Targeting DLK1 in neuroblastoma. Cancer Cell. https://doi.org/10.1016/j.ccell.2024.10.006
Vancouver
Anderson J. Targeting DLK1 in neuroblastoma. Cancer Cell. 2024. doi:10.1016/j.ccell.2024.10.006
BibTeX
@article{Anderson2024,
author = {Anderson, John},
title = {Targeting DLK1 in neuroblastoma},
journal = {Cancer Cell},
year = {2024},
doi = {10.1016/j.ccell.2024.10.006}
}
EUVIMED